A detailed history of Castleark Management LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Castleark Management LLC holds 43,250 shares of PRCT stock, worth $3.51 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
43,250
Previous 93,240 53.61%
Holding current value
$3.51 Million
Previous $5.7 Million 39.19%
% of portfolio
0.14%
Previous 0.24%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$56.31 - $84.99 $2.81 Million - $4.25 Million
-49,990 Reduced 53.61%
43,250 $3.46 Million
Q2 2024

Aug 13, 2024

BUY
$45.73 - $69.19 $1.63 Million - $2.47 Million
35,750 Added 62.18%
93,240 $5.7 Million
Q1 2024

May 15, 2024

BUY
$40.38 - $50.75 $2.32 Million - $2.92 Million
57,490 New
57,490 $2.84 Million
Q4 2022

Feb 09, 2023

BUY
$38.78 - $46.78 $41,106 - $49,586
1,060 Added 1.58%
67,960 $2.82 Million
Q3 2022

Nov 15, 2022

BUY
$30.9 - $50.65 $2.07 Million - $3.39 Million
66,900 New
66,900 $2.77 Million

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $3.62B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Castleark Management LLC Portfolio

Follow Castleark Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.